Genetic engineering is an advanced technology that modifies chromosomal DNA of animals and plants using molecular scissors (such as restriction enzyme that cut DNA into pieces). Genome engineering is now in the forefront of healthcare gaining traction with its use to fight diseases such as cancer, HIV, Malaria, sickle cell diseases. Pharma companies have entered this field to develop personalized medicines which can cure diseases more efficiently. For instance, in June 2014, Pfizer announced a collaboration with Cellectis, to develop a chimeric antigen receptor T-cell (CART-T cell) for anticancer immunotherapies.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by technology

Market overview

CRISPR

TALEN

ZFN

Other technologies

PART 07: Geographical segmentation

Genome engineering market in Americas

Genome engineering market in EMEA

Genome engineering market in APAC

PART 08: Market drivers

Potential opportunities in orphan diseases and

oncology

Improved specificity of CRISPR technology

Increased focus on human genomics

PART 09: Impact of drivers

PART 10: Market challenges

Ethical issues and adverse public perception

Stringent regulatory policies

Limited skilled technological specialist

PART 11: Impact of drivers and challenges

PART 12: Market trends

Advances in personalized medicine

Increasing partnerships between CROs and pharma

companies on validation studies

Increased development of synthetic biology

PART 13: Vendor landscape

Competitive scenario

PART 14: Key vendor analysis

Geographic presence - key vendor analysis

GenScript

Horizon Discovery Group

Integrated DNA Technologies

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio